These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26702132)

  • 1. A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis.
    Badman SG; Causer LM; Guy R; Tabrizi SN; Francis F; Donovan B; Whiley D;
    Sex Transm Infect; 2016 Aug; 92(5):350-2. PubMed ID: 26702132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.
    Muzny CA; Burkholder GA; Fry KR; Austin EL; Schwebke JR
    Sex Transm Dis; 2016 Aug; 43(8):483-8. PubMed ID: 27419815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and point-of-care tests for the diagnosis of
    Gaydos CA; Klausner JD; Pai NP; Kelly H; Coltart C; Peeling RW
    Sex Transm Infect; 2017 Dec; 93(S4):S31-S35. PubMed ID: 28684611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study.
    Garrett N; Mitchev N; Osman F; Naidoo J; Dorward J; Singh R; Ngobese H; Rompalo A; Mlisana K; Mindel A
    BMJ Open; 2019 Feb; 9(2):e026888. PubMed ID: 30782948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women.
    Schwebke JR; Gaydos CA; Davis T; Marrazzo J; Furgerson D; Taylor SN; Smith B; Bachmann LH; Ackerman R; Spurrell T; Ferris D; Burnham CA; Reno H; Lebed J; Eisenberg D; Kerndt P; Philip S; Jordan J; Quigley N
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation study of the Becton-Dickinson ProbeTec Qx (BDQx)
    Tipple C; Rayment M; Mandalia S; Walton L; O'Neill S; Murray J; O'Riordan A; Rebec M; Harrington L; Jones R; Wilkinson D
    Sex Transm Infect; 2018 Aug; 94(5):334-336. PubMed ID: 28108699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis.
    Webb B; Crampton A; Francis MJ; Hamblin J; Korman TM; Graham M
    Pathology; 2021 Feb; 53(2):257-263. PubMed ID: 33036769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa.
    Shephard M; Matthews S; Kularatne R; Andrewartha K; Blondeel K; Alvarez C; Camey E; Hançali A; Müller E; Haw A; Oumzil H; Golparian D; Ramirez DE; Kiarie J; Kurbonov F; Mirandola M; Peeling RW; Silva R; Thwin SS; Unemo M; Toskin I
    BMC Infect Dis; 2024 Mar; 24(Suppl 1):277. PubMed ID: 38438953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation and acceptability of point-of-care
    Hsieh YH; Lewis MK; Viertel VG; Myer D; Rothman RE; Gaydos CA
    Int J STD AIDS; 2020 Dec; 31(14):1364-1372. PubMed ID: 32998638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.
    Gaydos CA; Hobbs M; Marrazzo J; Schwebke J; Coleman JS; Masek B; Dize L; Jang D; Li J; Chernesky M
    Sex Transm Dis; 2016 Jun; 43(6):369-73. PubMed ID: 27196258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A service evaluation of the Gen-Probe APTIMA nucleic acid amplification test for Trichomonas vaginalis: should it change whom we screen for infection?
    Hathorn E; Ng A; Page M; Hodson J; Gaydos C; Ross JD
    Sex Transm Infect; 2015 Mar; 91(2):81-6. PubMed ID: 25170162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients.
    Sonkar SC; Wasnik K; Kumar A; Mittal P; Saluja D
    Infect Dis Poverty; 2016 May; 5():42. PubMed ID: 27146362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas Infection Rates in Males Presenting to the Emergency Department for Sexually Transmitted Infections.
    Territo HM; Wrotniak BH; Verni C; Burstein GR
    J Emerg Med; 2022 Jan; 62(1):1-8. PubMed ID: 34535306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine testing of Mycoplasma genitalium and Trichomonas vaginalis.
    Jenniskens ML; Veerbeek JH; Deurloo KL; van Hannen EJ; Thijsen SF
    Infect Dis (Lond); 2017 Jun; 49(6):461-465. PubMed ID: 28301989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland.
    Serwin AB; Bulhak-Koziol V; Sokolowska M; Golparian D; Unemo M
    APMIS; 2017 Sep; 125(9):840-843. PubMed ID: 28612378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.
    Craig-Kuhn MC; Granade C; Muzny CA; Van Der Pol B; Lillis R; Taylor SN; Schmidt N; Martin DH; Kissinger P
    Sex Transm Dis; 2019 May; 46(5):312-316. PubMed ID: 30601374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic-acid amplification testing of urine vs. patient complaint-driven evaluation.
    Chase PB; Hansen KL; Rothers J; Biros MH; Cartwright CP
    J Emerg Med; 2010 Jun; 38(5):572-7. PubMed ID: 18462909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients.
    Muzny CA; Tamhane AR; Eaton EF; Hudak K; Burkholder GA; Schwebke JR
    Int J STD AIDS; 2019 Mar; 30(4):344-352. PubMed ID: 30486764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.